CD79A and lung carcinoma: This study showed that C. pneumoniae seropositivity by microimmunofluorescence IgG or IgA antibodies was not associated with lung cancer, while individuals seropositive for CHSP-60 IgG antibodies showed a significantly increased lung cancer risk [10].